Microbot Medical (MBOT) vs SkyAI (SKYA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Microbot Medical (MBOT) has outperformed SkyAI (SKYA) over the past year, losing 65.3% versus a loss of 71.3%. SkyAI is the larger company by market cap ($73.1 million vs $71.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MBOT | SKYA |
|---|---|---|
| Share price | $1.07 | $1.69 |
| Market cap | $71.87M | $73.09M |
| 1-day change | -4.46% | -6.63% |
| YTD return | -44.00% | -10.84% |
| 1-year return | -65.33% | -71.27% |
| 5-year return | -84.38% | — |
| EPS (TTM) | $-0.25 | $-4.73 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.28 | $6.85 |
| 52-week low | $1.05 | $0.91 |
| Distance from 52-week high | -67.38% | -75.33% |
| Average volume | 647.83K | 316.21K |
| Shares outstanding | 67.16M | 43.25M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
MBOT vs SKYA FAQ
Which is bigger, Microbot Medical or SkyAI?
SkyAI (SKYA) is larger, with a market capitalization of $73.09M compared with $71.87M for Microbot Medical (MBOT).
Which stock has performed better over the past year, MBOT or SKYA?
MBOT returned -65.33% over the past 12 months, compared with -71.27% for SKYA (price return, excluding dividends). Past performance does not predict future results.
Are Microbot Medical and SkyAI in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.